ABBOTT LABORATORIES — Director's Dealing 2008

Apr 3, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-04-01

Reporting Person: REYNOLDS W ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-04-01	Common shares without par value	M	5124	$33.9503	Acquired	45601	Direct
2008-04-01	Common shares without par value	S	100	$55.10	Disposed	45501	Direct
2008-04-01	Common shares without par value	S	200	$55.092	Disposed	45301	Direct
2008-04-01	Common shares without par value	S	250	$55.102	Disposed	45051	Direct
2008-04-01	Common shares without par value	S	1300	$55.073	Disposed	43751	Direct
2008-04-01	Common shares without par value	S	900	$55.074	Disposed	42851	Direct
2008-04-01	Common shares without par value	S	1700	$55.063	Disposed	41151	Direct
2008-04-01	Common shares without par value	S	674	$55.053	Disposed	40477	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-04-01	Option (right to buy)	$33.9503	M	5124	Disposed	2008-04-23	Common shares (5124)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1747	Indirect
Common shares without par value	745	Indirect

Footnotes

F1: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11.

F2: The reporting person disclaims beneficial ownership of all securities held by her husband.

F3: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program.